Clinical Trials
3 trialsNCT00095628 2017-03-06
SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00354250 2013-06-05
Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00096499 2013-01-25
SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel
National Cancer Institute (NCI)
Phase 2 Completed